Imaging of Bone Sarcomas

Authors: Judd E. Cummings MD 1 , J. Andrew Ellzey MD 1 and Robert K. Heck MD 1
View More View Less
  • 1 From the University of Tennessee-Campbell Clinic, Department of Orthopaedic Surgery, Memphis, Tennessee.
Volume/Issue:
Volume 5: Issue 4
Online Publication Date:
Apr 2007
DOI:
https://doi.org/10.6004/jnccn.2007.0038
Full access

Identification, staging, and treatment of bone sarcomas rely on both clinical and imaging evaluations. Although conventional radiography remains the primary imaging modality for characterizing bone tumors, bone scintigraphy, computed tomography, magnetic resonance imaging, and positron emission tomography can each add information for staging and treatment planning.

If the inline PDF is not rendering correctly, you can download the PDF file here.

Correspondence: Robert K. Heck, MD, 1211 Union Avenue, Suite 510, Memphis, TN 38104. E-mail: rheck@campbellclinic.com
  • 1.

    Bielack SS, Kempf-Bielack B, Delling G. Prognostic factors in high-grade osteosarcoma of the extremities or trunk: an analysis of 1,702 patients treated on neoadjuvant Cooperative Osteosarcoma Study Group protocols. J Clin Oncol 2002;20:776–790.

    • Search Google Scholar
    • Export Citation
  • 2.

    Bacci G, Ferrari S, Bertoni F. Long-term outcome for patients with nonmetastatic osteosarcoma of the extremity treated at the Istituto Orthpedico Rizzoli according to the Istituto Ortopedico Rizzoli/Osteosarcoma-2 protocol: an updated report. J Clin Oncol 2000;18:4016–4027.

    • Search Google Scholar
    • Export Citation
  • 3.

    Bacci G, Picci P, Ruggieri P. The Istituto Rizzoli experience in 127 patients treated preoperatively with intravenous methotrexate (high versus moderate doses) and intraarterial cisplatin. Cancer 1990;65:2439–2553.

    • Search Google Scholar
    • Export Citation
  • 4.

    Goorin AM, Perez-Atayde A, Gebhardt M. Weekly high-dose methotrexate and doxorubicin for osteosarcoma: the Dana-Farber Cancer Institute/the Children's Hospital study III. J Clin Oncol 1987;5:1178–1184.

    • Search Google Scholar
    • Export Citation
  • 5.

    Kolb EA, Kushner BH, Garlick R. Long-term event-free survival after intensive chemotherapy for Ewing's family of tumors in children and young adults. J Clin Oncol 2003;18:3423–3430.

    • Search Google Scholar
    • Export Citation
  • 6.

    Link MP, Goorin MA, Miser AW. The effect of adjuvant chemotherapy on relapse-free survival in patients with osteosarcoma of the extremity. N Engl J Med 1986;314:1600–1606.

    • Search Google Scholar
    • Export Citation
  • 7.

    Mankin HJ, Hornicek FJ, Rosenberg AE. Survival data for 648 patients with osteosarcoma treated at one institution. Clin Orthop Rel Res 2004;429:286–291.

    • Search Google Scholar
    • Export Citation
  • 8.

    Marcus RB, Berrey BH, Graham-Pole J. The treatment of Ewing's sarcoma of bone at the University of Florida: 1969 to 1998. Clin Orthop Rel Res 2002;397:290–297.

    • Search Google Scholar
    • Export Citation
  • 9.

    Meyers PA, Heller G, Healey J. Chemotherapy for non-metastatic osteogenic sarcoma: the Memorial Sloan-Kettering experience. J Clin Oncol 1992;10:5–15.

    • Search Google Scholar
    • Export Citation
  • 10.

    Paulussen M, Ahrens S, Dunst J. Localized Ewing tumor of bone: final results of the Cooperative Ewing's Sarcoma Study CESS 86. J Clin Oncol 2001;19:1818–1829.

    • Search Google Scholar
    • Export Citation
  • 11.

    Rosen G, Caparros B, Huvos AG. Preoperative chemotherapy for osteogenic sarcoma: selection of postoperative adjuvant chemotherapy based on the response of the primary tumor to preoperative chemotherapy. Cancer 1982;49:1221–1230.

    • Search Google Scholar
    • Export Citation
  • 12.

    Rosen G, Nirenberg A, Caparros B. Osteogenic sarcoma: eight-percent, three-year, disease-free survival with combination chemotherapy (T-7). Natl Cancer Inst Monogr 1981;56:213–220.

    • Search Google Scholar
    • Export Citation
  • 13.

    Rougraff BY, Simon MA, Kneisl JS. Limb salvage compared with amputation for osteosarcoma of the distal end of the femur. A long-term oncological, functional, and quality-of-life study. J Bone Joint Surg Am 1994;76:649–656.

    • Search Google Scholar
    • Export Citation
  • 14.

    Kerns LL, Simon MA. Surgical theory, staging, definitions and treatment of musculoskeletal sarcomas. Surg Clin N Am 1983;63:671–696.

  • 15.

    Pommersheim WJ, Chew FS. Imaging, diagnosis, and staging of bone tumors: a primer. Semin Roentgenol 2004;39:361–372.

  • 16.

    Unni KK. Dahlin's Bone Tumors. General Aspects and Data on 11,087 Cases, 5th ed. Philadelphia: Lippincott-Raven, 1996:7–8.

  • 17.

    Peabody TD, Gibbs CP, Simon MA. Current concepts review. Evaluation and staging of musculoskeletal neoplasms. J Bone Joint Surg Am 1998;80:1204–1218.

    • Search Google Scholar
    • Export Citation
  • 18.

    Mankin HJ, Lange TA, Spanier SS. The hazards of biopsy in patients with malignant primary bone and soft-tissue tumors. J Bone Joint Surg Am 1982;64:1121–1127.

    • Search Google Scholar
    • Export Citation
  • 19.

    Mankin HJ, Mankin CJ, Simon MA. The hazards of the biopsy, revisited. J Bone Joint Surg Am 1996;78:656–662.

  • 20.

    Simon MA. Current concepts review. Biopsy of musculoskeletal tumors. J Bone Joint Surg Am 1982;64:1253–1257.

  • 21.

    Simon MA. Diagnostic and staging strategy for musculoskeletal tumors. In: Evarts CM, ed. Surgery of the Musculoskeletal System, 2nd ed. New York: Churchill Livingstone, 1990:4605–4634.

    • Search Google Scholar
    • Export Citation
  • 22.

    Temple HT, Bashore CJ. Staging of bone neoplasms: an orthopedic oncologist's perspective. Semin Musculoskelet Radiol 2000;4:17–23.

  • 23.

    Davies AM, Wellings RM. Imaging of bone tumors. Curr Opin Radiol 1992;4:32–38.

  • 24.

    Kricun ME. Parameters of diagnosis. In: Kricun ME, ed. Imaging of Bone Tumors. Philadelphia: WB Saunders, 1993:2–45.

  • 25.

    Lang P, Johnston JO, Arenal-Romero F. Advances in MR imaging of pediatric musculoskeletal neoplasms. Magn Reson Imaging Clin N Am 1998;6:579–604.

    • Search Google Scholar
    • Export Citation
  • 26.

    Massengill AD, Seeger LL, Eckardt JJ. The role of plain radiography, computed tomography, and magnetic resonance imaging in sarcoma evaluation. Hematol Oncol Clin North Am 1995;9:571–604.

    • Search Google Scholar
    • Export Citation
  • 27.

    Schnall M, Rosen M. Primer on imaging technologies for cancer. J Clin Oncol 2006;24:3225–3233.

  • 28.

    Manaster BJ. Musculoskeletal oncologic imaging. Int J Radiat Oncol Biol Phys 1991;21:1643–1651.

  • 29.

    Seeger LL, Widoff BE, Bassett LW. Preoperative evaluation of osteosarcoma: value of gadopentetate dimeglumine-enhanced MR imaging. AJR Am J Roentgenol 1991;157:347–351.

    • Search Google Scholar
    • Export Citation
  • 30.

    Wolf RE, Enneking WF. The staging and surgery of musculoskeletal neoplasms. Orthop Clin N Am 1996;27:473–481.

  • 31.

    Sanders TG, Parsons TW III. Radiographic imaging of musculoskeletal neoplasia. Cancer Control 2001;8:221–231.

  • 32.

    Enneking WF. A system of staging musculoskeletal neoplasms. Clin Orthop Rel Res 1986;204:9–24.

  • 33.

    Olson PN, Everson LI, Griffiths HJ. Staging of musculoskeletal tumors. Radiol Clin N Am 1994;32:151–162.

  • 34.

    Peh WC. The role of imaging in the staging of bone tumors. Crit Rev Oncol Hematol 1999;31:147–167.

  • 35.

    Teo HE, Peh WC. The role of imaging in the staging and treatment planning of primary malignant bone tumors in children. Eur Radiol 2004;14:465–475.

    • Search Google Scholar
    • Export Citation
  • 36.

    Brien EW, Mirra JM, Kerr R. Benign and malignant cartilage tumors of bone and joint: their anatomic and theoretical basis with an emphasis on radiology, pathology and clinical biology. I. The intramedullary cartilage tumors. Skeletal Radol 1997;26:325–353.

    • Search Google Scholar
    • Export Citation
  • 37.

    Simon MA, Krichner PT. Scintigraphic evaluation of primary bone tumors. Comparison of technetium-99m phosphate and gallium citrate imaging. J Bone Joint Surg 1980;62:759–764.

    • Search Google Scholar
    • Export Citation
  • 38.

    Hounsfield GN. Computerized transverse axial scanning (tomography): 1. Description of system. Br J Radiol 1973;46:1016–1022.

  • 39.

    Barentsz J, Takahashi S, Oyen W. Commonly used imaging techniques for diagnosis and staging. J Clin Oncol 2006;24:3234–3244.

  • 40.

    Sundaram M, McDonald DJ. Magnetic resonance imaging in the evaluation of the solitary bone tumor. Curr Opin Radiol 1990;2:697–702.

  • 41.

    Sundaram M, McGuire MH. Computed tomography or magnetic resonance for evaluating the solitary tumor or tumor-like lesion of bone? Skeletal Radiol 1988;17:393–401.

    • Search Google Scholar
    • Export Citation
  • 42.

    Richardson ML, Gillespy T. Magnetic resonance imaging. In: Kricun ME, ed. Imaging of Bone Tumors. Philadelphia: SB Saunders, 1993:358–446.

    • Search Google Scholar
    • Export Citation
  • 43.

    Berquist TH. Magnetic resonance imaging of musculoskeletal neoplasms. Clin Orthop Rel Res 1989;244:101–118.

  • 44.

    Jaramillo D, Laor T, Gebhardt MC. Pediatric musculoskeletal neoplasms. Evaluation with MR imaging. Magn Reson Imaging Clin N Am 1996;4:749–770.

    • Search Google Scholar
    • Export Citation
  • 45.

    Assoun J, Richardi G, Railhac JJ. Osteoid osteoma: MR imaging versus CT. Radiology 1994;18:981–984.

  • 46.

    Benedikt RA, Jelinek JS, Kransdorf MJ. MR imaging of soft-tissue masses: role of gadopentetate dimeglumine. J Magn Reson Imaging 1994;4:485–490.

    • Search Google Scholar
    • Export Citation
  • 47.

    Constable RT, Smith RC, Gore JC. Signal-to-noise and contrast in fast spine echo (FSE) and inversion recovery FSE imaging. J Comput Assist Tomogr 1992;16:41–47.

    • Search Google Scholar
    • Export Citation
  • 48.

    Holscher HC, Bloem JL, van der Woude HJ. Can MRI predict the histopathological response in patients with osteosarcoma after the first cycle of chemotherapy? Clin Radiol 1995;50:384–390.

    • Search Google Scholar
    • Export Citation
  • 49.

    Holscher HC, van der Woude HJ, Hermans J. Magnetic resonance relaxation times of normal tissue in the course of chemotherapy: a study in patients with bone sarcoma. Skeletal Radiol 1994;23:181–185.

    • Search Google Scholar
    • Export Citation
  • 50.

    Li KC, Hopkins KL, Moore SG. Magnetization transfer contrast MRI of musculoskeletal neoplasms. Skeletal Radiol 1995;24:21–25.

  • 51.

    Ma LD, Frassica FJ, Scott WW. Differentiation of benign and malignant musculoskeletal tumors: potential pitfalls with MR imaging. Radiographics 1995;15:349–366.

    • Search Google Scholar
    • Export Citation
  • 52.

    Mirowitz SA, Apicella P, Reinus WR. MR imaging of bone marrow lesions: relative conspicuousness on T1-weighted, fat-suppressed T2-weighted, and STIR images. AJR Am J Roentgenol 1994;162:215–221.

    • Search Google Scholar
    • Export Citation
  • 53.

    Aisen AM, Martel W, Braunstein EM. MRI and CT evaluation of primary bone and soft-tissue tumors. AJR Am J Roentgenol 1986;146:749–756.

  • 54.

    Bloem JL, Taminiau AH, Eulderink F. Radiologic staging of primary bone sarcoma: MR imaging, scintigraphy, angiography, and CT correlated with pathologic examination. Radiology 1988;169:805–810.

    • Search Google Scholar
    • Export Citation
  • 55.

    Bohndorf K, Reiser M, Lochner B. Magnetic resonance imaging of primary tumors and tumor-like lesions of bone. Skeletal Radiol 1986;15:511–517.

    • Search Google Scholar
    • Export Citation
  • 56.

    Boyko OB, Cory DA, Cohen MD. MR imaging of osteogenic and Ewing's sarcoma. AJR Am J Roentgenol 1987;148:317–322.

  • 57.

    Cohen IJ, Hadar H, Schreiber T. Primary bone tumor respectability: the value of serial MRI studies in the determination of the feasibility, timing, and extent of tumor resection. J Pediatr Orthop 1994;14:781–787.

    • Search Google Scholar
    • Export Citation
  • 58.

    Petasnick JP, Turner DA, Charters JR. Soft-tissue masses of the locomotor system: comparison of MR imaging with CT. Radiology 1986;160:125–133.

    • Search Google Scholar
    • Export Citation
  • 59.

    Pettersson H, Gillespy T, Hamlin DJ. Primary musculoskeletal tumors: examination with MR imaging compared to conventional modalities. Radiology 1987;164:237–241.

    • Search Google Scholar
    • Export Citation
  • 60.

    Vanel D, Verstraete KL, Shapeero LG. Primary tumors of the musculoskeletal system. Radiol Clin N Am 1997;35:213–237.

  • 61.

    Zimmer WD, Berquist TH, McLeod RA. Bone tumors: magnetic resonance imaging versus computed tomography. Radiology 1985;155:709–718.

  • 62.

    Enneking WF, Kagan A. The implications of ``skip'' metastases in osteosarcoma. Clin Orthop Rel Res 1975;111:33–41.

  • 63.

    Malawer MM, Dunham WK. Skip metastases in osteosarcoma: recent experience. J Surg Oncol 1983;22:236–245.

  • 64.

    Sajadi KR, Heck HK, Neel MD. The incidence and prognosis of osteosarcoma skip metastases. Clin Orthop Rel Res 2004;426:92–96.

  • 65.

    Wuisman P, Enneking WF. Prognosis for patients who have osteosarcoma with skip metastasis. J Bone Joint Surg Am 1990;72:60–68.

  • 66.

    Aoki J, Endo K, Watanabe H. FDG-PET for evaluating musculoskeletal tumors: a review. J Orthop Sci 2003;8:435–441.

  • 67.

    Feldman F, van Heertum R, Manos C. 18FDG PET scanning of benign and malignant musculoskeletal lesions. Skeletal Radiol 2003;32:201–208.

  • 68.

    Gilkey FW, Moser RP. The biology of cartilage. In: Moser RP, ed. Cartilaginous Tumors of the Skeleton. Philadelphia: Hanley and Belfus, 1990:1–7.

    • Search Google Scholar
    • Export Citation
  • 69.

    Lee FY, Yu J, Chang SS. Diagnostic value and limitations of fluorine-18 fluorodeoxyglucose positron emission tomography for cartilaginous tumors of bone. J Bone Joint Surg Am 2004;86:2677–2685.

    • Search Google Scholar
    • Export Citation
  • 70.

    Poole AR. Physiology of cartilage formation, function and destruction. In: Cruess RC, ed. The Musculoskeletal System. Embryology, Biochemistry and Physiology. New York: Churchill Livingstone, 1982:286–230.

    • Search Google Scholar
    • Export Citation
  • 71.

    Dehdashti F, Siegel BA, Griffeth LK. Benign versus malignant intraosseous lesions: discrimination by means of PET with 2-[F-18]fluoro-2-deoxy-d-glucose. Radiology 1996;200:243–247.

    • Search Google Scholar
    • Export Citation
  • 72.

    Schulte M, Brecht-Krauss D, Heymer B. Grading of tumors and tumorlike lesions of bone: evalution by FDG PET. J Nucl Med 2000;41:1695–1701.

  • 73.

    Guhlmann A, Brecht-Krauss D, Suger G. Chronic osteomyelitis: detection with FDG PET and correlation with histopathologic findings. Radiology 1998;206:749–754.

    • Search Google Scholar
    • Export Citation
  • 74.

    Palmer WE, Rosenthal DI, Schoenberg OI. Quantification of inflammation in the wrist with gadolinium-enhanced MR imaging and PET with 2-[F-18]-fluoro-2-deoxy-d-glucose. Radiology 1995;196:647–655.

    • Search Google Scholar
    • Export Citation
  • 75.

    Akoi J, Sone S, Fujioka F. MR of enchondroma and chondrosarcoma: rings and arcs of Gd-DTPA enhancement. J Comput Assist Tomogr 1991;15:1011–1016.

    • Search Google Scholar
    • Export Citation
  • 76.

    Kern KA, Brunetti A, Norton JA. Metabolic imaging of human extremity musculoskeletal tumors by PET. J Nucl Med 1988;29:181–186.

  • 77.

    Strauss LG. Fluorine-18 deoxyglucose and false-positive results: a major problem in the diagnostics of oncological patients. Eur J Nucl Med 1996;23:1409–1415.

    • Search Google Scholar
    • Export Citation
  • 78.

    Garcia JR, Kim EE, Wong FCL. Comparison of fluorine-18-FDG PET and technetium-99m-MIBI SPECT in evaluation of musculoskeletal sarcomas. J Nucl Med 1996;37:1476–1479.

    • Search Google Scholar
    • Export Citation
  • 79.

    Kole AC, Nieweg OE, van Ginkel RJ. Detection of local recurrence of soft-tissue sarcoma with positron emission tomography using [18F]fluorodeoxyglucose. Ann Surg Oncol 1997;4:57–63.

    • Search Google Scholar
    • Export Citation
  • 80.

    Lucas JD, O'Doherty MJ, Wong JCH. Evaluation of fluorodeoxyglucose positron emission tomography in the management of soft-tissue sarcomas. J Bone Joint Surg Br 1998;80:441–447.

    • Search Google Scholar
    • Export Citation
Copyright:
Copyright © 2007 by the National Comprehensive Cancer Network
Page Numbers:
438–447
Article Category:
Research Article
Received:
24 Oct 2006
Accepted:
13 Nov 2006
Print Publication Date:
01 Apr 2007
Online Publication Date:
Apr 2007
Keywords:
Bone sarcoma; imaging; staging
All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 67 18 2
PDF Downloads 37 22 0
EPUB Downloads 0 0 0